Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCORD 03: Intensification Therapy for Anal Canal Cancer
NCT00003652Phase 3Completed
- Sponsor
- Unicancer
- Start
- Jan 1999
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cisplatin, fluorouracil in anal cancer, sponsored by Unicancer. Started Jan 1999; status: completed.
02
Drugs
cisplatinfluorouracil
03
Conditions
anal cancer
Beyond the preview
Go deeper on NCT00003652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003652.